Reinhard A Seger

Summary

Affiliation: University Children's Hospital
Country: Switzerland

Publications

  1. doi request reprint Modern management of chronic granulomatous disease
    Reinhard A Seger
    Division Immunology Haematology, University Children s Hospital of Zurich, Zurich, Switzerland
    Br J Haematol 140:255-66. 2008
  2. ncbi request reprint Hematopoietic stem cell transplantation for chronic granulomatous disease
    Reinhard A Seger
    Division of Immunology Hematology BMT, University Children s Hospital, Steinwiesstrasse 75, Zurich 8032, Switzerland
    Immunol Allergy Clin North Am 30:195-208. 2010
  3. ncbi request reprint Chronic granulomatous disease: recent advances in pathophysiology and treatment
    R A Seger
    Division of Immunology Haematology BMT, University Children s Hospital of Zurich, Zurich, Switzerland
    Neth J Med 68:334-40. 2010
  4. pmc Restoration of NET formation by gene therapy in CGD controls aspergillosis
    Matteo Bianchi
    Division of Immunology Haematology BMT, University Children s Hospital Zurich, Zurich, Switzerland
    Blood 114:2619-22. 2009
  5. doi request reprint Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen
    Janine Reichenbach
    Division of Immunology, University Children s Hospital, Zurich, Switzerland
    Clin Infect Dis 49:1703-10. 2009
  6. ncbi request reprint Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000
    Reinhard A Seger
    European Group for Blood and Marrow Transplantation EBMT and the European Society for Immunodeficiencies ESID, Division of Immunology Hematology, University Children s Hospital, Zurich, Switzerland
    Blood 100:4344-50. 2002
  7. doi request reprint First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching
    Janine Reichenbach
    University Children s Hospital Zurich, Division of Immunology Hematology BMT, Steinwiesstrasse 75, CH 8032 Zurich, Switzerland
    Pediatrics 122:e778-82. 2008
  8. ncbi request reprint Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation
    Jana M Pachlopnik Schmid
    Division of Immunology Hematology BMT, University Children s Hospital, Zurich, Switzerland
    Pediatrics 117:e1049-56. 2006
  9. ncbi request reprint Gene therapy of hematopoietic stem cells: strategies for improvement
    Johann P Hossle
    Division of Immunology Hematology Oncology, University Children s Hospital Zurich, CH 8032 Zurich, Switzerland
    News Physiol Sci 17:87-92. 2002

Detail Information

Publications9

  1. doi request reprint Modern management of chronic granulomatous disease
    Reinhard A Seger
    Division Immunology Haematology, University Children s Hospital of Zurich, Zurich, Switzerland
    Br J Haematol 140:255-66. 2008
    ..However, it may offer some transitory benefits and has helped in a few cases to overcome life-threatening infections...
  2. ncbi request reprint Hematopoietic stem cell transplantation for chronic granulomatous disease
    Reinhard A Seger
    Division of Immunology Hematology BMT, University Children s Hospital, Steinwiesstrasse 75, Zurich 8032, Switzerland
    Immunol Allergy Clin North Am 30:195-208. 2010
    ..This article addresses recent progress in HSCT for CGD, delineates present limitations, and points to future developments...
  3. ncbi request reprint Chronic granulomatous disease: recent advances in pathophysiology and treatment
    R A Seger
    Division of Immunology Haematology BMT, University Children s Hospital of Zurich, Zurich, Switzerland
    Neth J Med 68:334-40. 2010
    ..Fatal' granulomatous disease 50 years later has become a chronic inflammatory disorder with a median survival of 30 years and is of interest to both paediatricians and internists...
  4. pmc Restoration of NET formation by gene therapy in CGD controls aspergillosis
    Matteo Bianchi
    Division of Immunology Haematology BMT, University Children s Hospital Zurich, Zurich, Switzerland
    Blood 114:2619-22. 2009
    ....
  5. doi request reprint Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen
    Janine Reichenbach
    Division of Immunology, University Children s Hospital, Zurich, Switzerland
    Clin Infect Dis 49:1703-10. 2009
    ....
  6. ncbi request reprint Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000
    Reinhard A Seger
    European Group for Blood and Marrow Transplantation EBMT and the European Society for Immunodeficiencies ESID, Division of Immunology Hematology, University Children s Hospital, Zurich, Switzerland
    Blood 100:4344-50. 2002
    ....
  7. doi request reprint First successful bone marrow transplantation for X-linked chronic granulomatous disease by using preimplantation female gender typing and HLA matching
    Janine Reichenbach
    University Children s Hospital Zurich, Division of Immunology Hematology BMT, Steinwiesstrasse 75, CH 8032 Zurich, Switzerland
    Pediatrics 122:e778-82. 2008
    ....
  8. ncbi request reprint Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation
    Jana M Pachlopnik Schmid
    Division of Immunology Hematology BMT, University Children s Hospital, Zurich, Switzerland
    Pediatrics 117:e1049-56. 2006
    ..Our observations suggest that patients with hypomorphic NEMO mutations and repeated infections may experience inflammatory dysregulation...
  9. ncbi request reprint Gene therapy of hematopoietic stem cells: strategies for improvement
    Johann P Hossle
    Division of Immunology Hematology Oncology, University Children s Hospital Zurich, CH 8032 Zurich, Switzerland
    News Physiol Sci 17:87-92. 2002
    ..Lentiviral vectors combined with positive selection strategies using conditional cell-growth switches should allow for improvement...